Cargando…

XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer

Introduction: Patient-derived xenografts (PDX) can be used to explore tumour pathophysiology and could be useful to better understand therapeutic response in breast cancer. PDX from mammary tumours are usually made from metastatic tumours. Thus, PDX from primary mammary tumours or after neoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veyssière, Hugo, Passildas, Judith, Ginzac, Angeline, Lusho, Sejdi, Bidet, Yannick, Molnar, Ioana, Bernadach, Maureen, Cavaille, Mathias, Radosevic-Robin, Nina, Durando, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258709/ https://www.ncbi.nlm.nih.gov/pubmed/34249349 http://dx.doi.org/10.12688/f1000research.26873.3

Ejemplares similares

INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer
por: Veyssière, Hugo, et al.
Publicado: (2021)

PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer
por: Lusho, Sejdi, et al.
Publicado: (2020)

Sister Mary Joseph Nodules: A Case Report about a Rare Location of Skin Metastasis
por: Leyrat, Brice, et al.
Publicado: (2021)

Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report
por: Wong-Chong, Jonathan, et al.
Publicado: (2021)

Adapted Physical Activity for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Trastuzumab Against HER2 (APACAN2): A Protocol for a Feasibility Study
por: Ginzac, Angeline, et al.
Publicado: (2021)

Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients
por: Lusho, Sejdi, et al.
Publicado: (2021)

Circulating proteins as predictive and prognostic biomarkers in breast cancer
por: Veyssière, Hugo, et al.
Publicado: (2022)

Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial
por: Ginzac, Angeline, et al.
Publicado: (2023)

Durable Response to Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring MET Intron 14 Mutation: A Case Report
por: Leyrat, Brice, et al.
Publicado: (2021)

RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire
por: Veyssiere, Hugo, et al.
Publicado: (2023)

Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers
por: Bernadach, Maureen, et al.
Publicado: (2021)

Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study
por: Herrmann, Tressie, et al.
Publicado: (2021)

hPG(80) (circulating progastrin) as a blood biomarker for high-grade glial tumors: A pilot study
por: Casile, Melanie, et al.
Publicado: (2023)

Quality of life for older patients with cancer: a review of the evidence supporting melatonin use
por: Ginzac, Angeline, et al.
Publicado: (2020)

A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patients
por: Ginzac, Angeline, et al.
Publicado: (2020)

Preoperative stereotactic radiosurgery for brain metastases: the STEP study protocol for a multicentre, prospective, phase-II trial
por: Ginzac, Angeline, et al.
Publicado: (2021)

Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition
por: Cavaillé, Mathias, et al.
Publicado: (2020)

Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer
por: Passildas‐Jahanmohan, Judith, et al.
Publicado: (2021)

Early Onset Multiple Primary Tumors in Atypical Presentation of Cowden Syndrome Identified by Whole-Exome-Sequencing
por: Cavaillé, Mathias, et al.
Publicado: (2018)

Feedback of extended panel sequencing in 1530 patients referred for suspicion of hereditary predisposition to adult cancers
por: Cavaillé, Mathias, et al.
Publicado: (2020)

Detection Rate and Spectrum of Pathogenic Variations in a Cohort of 83 Patients with Suspected Hereditary Risk of Kidney Cancer
por: Ouedraogo, Zangbéwendé Guy, et al.
Publicado: (2023)

Case Series of 11 CDH1 Families (47 Carriers) Including Incidental Findings, Signet Ring Cell Colon Cancer and Review of the Literature
por: Lepage, Mathis, et al.
Publicado: (2023)

New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer
por: Khaled, Noura, et al.
Publicado: (2019)

Rare duplication of the CDC73 gene and atypical hyperparathyroidism‐jaw tumor syndrome: A case report and review of the literature
por: Garrigues, Guilhaume, et al.
Publicado: (2023)

Differential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer Xenograft
por: Skrbo, Nirma, et al.
Publicado: (2014)

The luminance ratio of autofluorescence in a xenograft mouse model is stable through tumor growth stages
por: Sumi, Shigeki, et al.
Publicado: (2018)

Is BRCA2 involved in early onset colorectal cancer risk?
por: Gay‐Bellile, Mathilde, et al.
Publicado: (2019)

Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts
por: Coussy, Florence, et al.
Publicado: (2020)

Diagnosis of PTEN mosaicism: the relevance of additional tumor DNA sequencing. A case report and review of the literature
por: Cavaillé, Mathias, et al.
Publicado: (2023)

A simple and reproducible prognostic index in luminal ER-positive breast cancers
por: Castellano, I., et al.
Publicado: (2013)

Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy
por: Mione, Cécile, et al.
Publicado: (2023)

Identification of a novel pathogenic variant in PALB2 and BARD1 genes by a multigene sequencing panel in triple negative breast cancer in Morocco
por: Laraqui, Abdelilah, et al.
Publicado: (2021)

THE TOTAL LUMINOUS EFFICIENCY OF LUMINOUS BACTERIA
por: Harvey, E. Newton
Publicado: (1925)

Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models
por: Moestue, Siver A, et al.
Publicado: (2010)

Enhanced luminance sensitivity on color and luminance pedestals: Threshold measurements and a model of parvocellular luminance processing
por: Shooner, Christopher, et al.
Publicado: (2020)

The luminous and the grey
por: Batchelor, David
Publicado: (2014)

The SNORD115 (H/MBII-52) and SNORD116 (H/MBII-85) gene clusters at the imprinted Prader–Willi locus generate canonical box C/D snoRNAs
por: Bortolin-Cavaillé, Marie-Line, et al.
Publicado: (2012)

Prognostic Value of Lymphangiogenesis Determinants in Luminal and Non-luminal Breast Carcinomas
por: Widodo, Irianiwati, et al.
Publicado: (2018)

Salmonella Transiently Reside in Luminal Neutrophils in the Inflamed Gut
por: Loetscher, Yvonne, et al.
Publicado: (2012)

Lipidomics-based tissue heterogeneity in specimens of luminal breast cancer revealed by clustering analysis of mass spectrometry imaging: A preliminary study
por: Aramaki, Shuhei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kopmh43u3lqfitps7g22h83a5i